Like many of you, I don't get my hopes up when I hear about possible treatments being studied that might slow PD. I recently read this one in Parkinsons News Today about buntanetap. Does anyone have the inside scoop on whether this one might be different?
Thanks!
A great recent interview! Approximately 30 minutes. Well worth a look.
For the drugs that are supposed to break down alpha synuclein protein clumps, is there a way for them to actually monitor if the break down is occurring, as opposed to just looking at symptom relief? It seems that if there is a treatment that can slow the progression of dopamine neurons dying, it wouldn't necessarily provide symptom relief since the treatment isn't replenishing the dopamine neurons.
Anyone here participating in this trial?buntanetap 
Annovis Bio Buntanetap 
Annovis Bio Announces Approval for EU Clinical Trial Sites for the Phase 3 Study of Buntanetap for the Treatment of Parkinson's Disease
Annovis Bio have published the results of their dose-finding, biomarker study of buntanetap in 14 early Alzheimers & 14 Parkinsons patients
